Atlanpole Biotherapies – Bio-cluster of Western France, including Pays de la Loire, Bretagne & Centre Val de Loire regions
Atlanpole Biotherapies is the bio-cluster of Western France, including Pays de la Loire, Bretagne and Centre Val de Loire regions. It co-ordinates the work of over 150 members, including laboratories, companies and technological platforms and provides support for public-private collaborations, along the entire bio-medicine value chain from target discovery to clinical evaluation.
The main innovation areas of its members are:
- Immunobiotherapies: transplantation, oncology, inflammation, auto-immune diseases etc.
- Radiopharmaceuticals: radionuclides production, radioimmunoconjugates used in diagnostics or therapy, whole body imaging (preclinical & clinical), cancer research, education etc.
- Regenerative medicine: cell therapy, gene therapy, biomaterials etc.
- Innovative technologies for biotherapies: biomarkers, vectors, medical devices etc.
Atlanpole Biotherapies has a strong expertise in SME internationalisation and organises yearly activities for its SME members in European and international events, with the aim of generating trans-national R&D or business collaborations.